Rowan Gardner is a seasoned entrepreneur and CEO with over 30 years of experience in health tech, digital health, deep tech and biotech. She played a part in one of Oxford University's first spin-outs, Oxford Molecular Group, in 1989, and later listed it on the main London Stock Exchange in 1994.

Rowan is a fervent advocate for Oxford and currently serves as Chief Business and Investment Officer at Precision Life.